MURINE STRAIN DIFFERENCES IN METABOLISM AND BLADDER TOXICITY OF CYCLOPHOSPHAMIDE

被引:29
作者
FRAISER, L [1 ]
KEHRER, JP [1 ]
机构
[1] UNIV TEXAS,COLL PHARM,DIV PHARMACOL & TOXICOL,AUSTIN,TX 78712
关键词
CYCLOPHOSPHAMIDE; HEMORRHAGIC CYSTITIS; STRAIN DIFFERENCE; METABOLISM; BLADDER INJURY; ACROLEIN;
D O I
10.1016/0300-483X(92)90007-2
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Cyclophosphamide (CP) undergoes metabolic activation, generating phosphoramide mustard and acrolein which are believed to be responsible for the cytostatic and toxic effects, respectively. In this study, CP-induced bladder toxicity (hemorrhagic cystitis) was found to be significantly greater in the ICR than the C57BL/6N (C-57) strain of mice. Strain differences exist in the distribution of CP metabolites to the bladder, as evidenced by consistently higher levels of acrolein equivalents measured in the urine of the sensitive ICR strain. These differences may arise from strain variation in the oxidative metabolism of CP by the mixed-function oxidase system. However, intrinsic factors within the bladder may also be involved in the resistance exhibited by C-57 mice. Support for this hypothesis is provided by the significant increase in hemorrhagic response and permeability of ICR compared to C-57 bladders exposed to equivalent levels of acrolein by intravesicle instillation. Basal protein thiol levels were higher in C-57 than in the ICR strain. However, the effects of acrolein on protein thiol content did not correlate with toxicity suggesting that these groups are not the critical targets for CP-induced bladder injury.
引用
收藏
页码:257 / 272
页数:16
相关论文
共 37 条
[1]   METABOLIC-ACTIVATION AND CYTO-TOXICITY OF CYCLOPHOSPHAMIDE IN PRIMARY CULTURES OF POSTNATAL RAT HEPATOCYTES [J].
ACOSTA, D ;
MITCHELL, DB .
BIOCHEMICAL PHARMACOLOGY, 1981, 30 (23) :3225-3230
[2]   FLUOROMETRIC DETERMINATION OF ACROLEIN AND RELATED COMPOUNDS WITH M-AMINOPHENOL [J].
ALARCON, RA .
ANALYTICAL CHEMISTRY, 1968, 40 (11) :1704-&
[3]  
BAILLIE TA, 1991, ACCOUNTS CHEM RES, V4, P265
[4]   CYCLOPHOSPHAMIDE AND HEMORRHAGIC CYSTITIS [J].
BENNETT, AH .
JOURNAL OF UROLOGY, 1974, 111 (05) :603-606
[5]  
BURKE MD, 1974, DRUG METAB DISPOS, V2, P583
[6]  
CHIJIIWA K, 1983, CANCER RES, V43, P5205
[7]   TOXIC AND NONTOXIC CHANGES INDUCED IN THE UROTHELIUM BY XENOBIOTICS [J].
COHEN, SM .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1989, 101 (03) :484-498
[8]   CYCLOPHOSPHAMIDE CYSTITIS - IDENTIFICATION OF ACROLEIN AS THE CAUSATIVE AGENT [J].
COX, PJ .
BIOCHEMICAL PHARMACOLOGY, 1979, 28 (13) :2045-2049
[9]  
FOLEY GE, 1961, CANCER RES, V21, P57
[10]  
FORNI AM, 1964, CANCER, V17, P1348, DOI 10.1002/1097-0142(196410)17:10<1348::AID-CNCR2820171017>3.0.CO